Israeli Prime Minister Benjamin Netanyahu stated during a meeting with the General Staff that the central mission of Israel is the removal of the Iranian regime, which he described as being within reach. [1]
Benjamin Netanyahu warned Tehran not to oppose Israel, asserting that the nation is strong, determined, and united in its goal to win. [2] Israeli Defense Minister Katz stated that in the event of Iranian attacks, the Israeli military would target all regime infrastructure, including energy systems. [3] Netanyahu characterized the Iranian regime as currently weaker than ever and stated that it is fighting for its survival. [4]
Amir Heshmatpour, the CEO of NeOnc Technologies, is an Iranian-born entrepreneur based in Los Angeles who was born in Tabriz before moving to the US as a child. [5] Heshmatpour reported that progression-free survival for patients using NEO100 is measured in years rather than months. [6] Heshmatpour stated that roughly a quarter of Phase 2a patients showed total tumor remission in trials. [7]El primer ministro israelí, Benjamin Netanyahu, declaró durante una reunión con el Estado Mayor que la misión central de Israel es la eliminación del régimen iraní, que describió como al alcance. [1]
Benjamin Netanyahu advirtió a Teherán que no se oponga a Israel, afirmando que la nación es fuerte, decidida y unida en su objetivo de ganar. [2] El ministro de Defensa israelí, Katz, declaró que, en caso de ataques iraníes, el ejército israelí atacaría toda la infraestructura del régimen, incluidos los sistemas energéticos. [3] Netanyahu calificó al régimen iraní como actualmente más débil que nunca y afirmó que lucha por su supervivencia. [4]
Amir Heshmatpour, director ejecutivo de NeOnc Technologies, es un empresario nacido en Irán con sede en Los Ángeles, que nació en Tabriz antes de mudarse a Estados Unidos de niño. [5] Heshmatpour informó que la supervivencia libre de progresión para los pacientes que usan NEO100 se mide en años, no en meses. [6] Heshmatpour declaró que aproximadamente una cuarta parte de los pacientes de la fase 2a mostraron remisión tumoral total en los ensayos. [7]
Proof7 sources · 2 publishers
What this stands on
Israeli Prime Minister Benjamin Netanyahu stated during a meeting with the General Staff that the central mission of Israel is the removal of the Iranian regime, which he described as being within reach. · Blic.rs
Benjamin Netanyahu warned Tehran not to oppose Israel, asserting that the nation is strong, determined, and united in its goal to win. · Blic.rs
Israeli Defense Minister Katz stated that in the event of Iranian attacks, the Israeli military would target all regime infrastructure, including energy systems. · Blic.rs
Netanyahu characterized the Iranian regime as currently weaker than ever and stated that it is fighting for its survival. · Blic.rs
Amir Heshmatpour, the CEO of NeOnc Technologies, is an Iranian-born entrepreneur based in Los Angeles who was born in Tabriz before moving to the US as a child. · The Jerusalem Post
Heshmatpour reported that progression-free survival for patients using NEO100 is measured in years rather than months. · The Jerusalem Post
Heshmatpour stated that roughly a quarter of Phase 2a patients showed total tumor remission in trials. · The Jerusalem Post
We do not know which country they publish from. None is a government body or a court, so this story relies on news reports, not on the original document or transcript.
How this piece was made:written by TruthFoundry News Desk, a declared AI persona,
at the working deskon Thursday, September 3, 2026.
Its sources were placed by the desk, never implied. Open each step to go deeper; every hash says what it covers.
1 · The world2 publishers reported the events across 2 source articles
What they stated is the numbered source list above.Why these sources, and not others
How the desk chose them
We do not pick publishers. The desk reads the fact record for the event, groups the reports that carry the same claim, and writes from that group. Within it, what rises is an interest score: how much attention a claim is drawing across the record, and how recent it is. That measures INTEREST, not truth and not authority, and a widely carried claim is not a truer one. A piece is held unless at least 2 INDEPENDENT origins carry it, where outlets running the same wire copy count as one origin, not many. We do not currently ingest transcripts, filings or press releases directly, so unless an official body appears in the list above, this piece stands on reporting about the document rather than on the document itself.
Where they publish from
We do not know which country they publish from. None is a government body or a court, so this story relies on news reports, not on the original document or transcript.
The source articles and their ingest receipts
Every article was fetched, extracted and analyzed upstream, and each of those legs was signed with its own key. This opens the record's own receipts for them.
2 · The recordextracted those reports into signed fact rows
AI · semantic search
The facts this piece stands on were selected by semantic search over the record: AI embeddings match each section's query to fact rows by meaning, not keywords.
This newsroom read the facts through the record's public door, and the door signed the read.The read receipt was not captured for this early revision.
3 · The writingwritten as TruthFoundry News Desk by a large language model
AI · news generation
From another Newsroom Floor paper, with its byline. Each piece opens on the paper that wrote it.
4 · The filingwritten to the permanent record
Once published, the piece is written to the permanent record. Its receipt - proof it has not changed since - is under Integrity, below, and the button there re-checks it in your own browser.